Organogenesis Holdings (ORGO) Non Operating Income (2017 - 2026)
Organogenesis Holdings (ORGO) posted Non Operating Income of $112000.0 for Q2 2026, down 73.21% on a QoQ basis from $418000.0 in Q1 2026, and down 84.91% year-over-year from $742000.0 in Q2 2025.
Powered by 
Analysis
Organogenesis Holdings (ORGO) Non Operating Income (2017 - 2026) Analysis & Trends
Organogenesis Holdings has reported Non Operating Income for 10 years, with the latest figure at $112000.0 in Q2 2026.
- On a quarterly basis, Non Operating Income fell 84.91% year-over-year to $112000.0 in Q2 2026; TTM through Jun 2026 was $1.1 million, a 16.59% decrease from a year earlier, with the FY2025 full-year figure at $2.3 million, up 249.34% from the prior year.
- Non Operating Income was $112000.0 for Q2 2026 at Organogenesis Holdings, down from $418000.0 in the prior quarter.
- The five-year high for Non Operating Income was $963000.0 in Q1 2025, with the low at -$751000.0 in Q2 2022.
- Average Non Operating Income over 5 years is -$159555.6, with a median of -$416000.0 recorded in 2023.
- The sharpest annual moves came in 2023 and 2025: Non Operating Income tumbled 1563.89% in 2023, then surged 305.88% in 2025.
- Over 5 years, Non Operating Income stood at $36000.0 in 2022, then sank by 1563.89% to -$527000.0 in 2023, then surged by 106.45% to $34000.0 in 2024, then soared by 305.88% to $138000.0 in 2025, then slipped by 18.84% to $112000.0 in 2026.
- The last three Non Operating Income figures came in at $112000.0 (Q2 2026), $418000.0 (Q1 2026), and $138000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.63 Bn | 178.03 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 124.13 Bn | 118.91 Bn | 1.96 Bn | 82.70 Mn |
| 3 | Medtronic | 118.51 Bn | 109.69 Bn | 6.34 Bn | - |
| 4 | Stryker | 106.53 Bn | 103.06 Bn | 4.50 Bn | 46.00 Mn |
| 5 | Boston Scientific | 66.52 Bn | 65.98 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.57 Bn | 45.32 Bn | 1.35 Bn | 6.60 Mn |
| 7 | Alcon | 34.00 Bn | 32.55 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.03 Bn | 30.08 Bn | 830.00 Mn | - |
| 9 | Steris | 21.12 Bn | 20.64 Bn | 684.20 Mn | -12.30 Mn |
| 10 | Organogenesis Holdings | 202.66 Mn | 155.82 Mn | 20.08 Mn | 112,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 112,000.00 |
| Mar 31, 2026 | 418,000.00 |
| Dec 31, 2025 | 138,000.00 |
| Sep 30, 2025 | 433,000.00 |
| Jun 30, 2025 | 742,000.00 |
| Mar 31, 2025 | 963,000.00 |
| Dec 31, 2024 | 34,000.00 |
| Sep 30, 2024 | -419,000.00 |
| Jun 30, 2024 | -648,000.00 |
| Mar 31, 2024 | -491,000.00 |
| Dec 31, 2023 | -527,000.00 |
| Sep 30, 2023 | -413,000.00 |
| Jun 30, 2023 | -566,000.00 |
| Mar 31, 2023 | -626,000.00 |
| Dec 31, 2022 | 36,000.00 |
| Sep 30, 2022 | -567,000.00 |
| Jun 30, 2022 | -751,000.00 |
| Mar 31, 2022 | -740,000.00 |
| Dec 31, 2021 | -862,000.00 |
| Sep 30, 2021 | -3.38 Mn |